Literature DB >> 16905957

A novel factor XI gene mutation associated with mild factor XI deficiency in a symptomatic patient.

Khaled M Ramadan1, Orla McNulty, Julia Am Anderson, Francis G Jones, Paul C Winter.   

Abstract

Congenital factor XI deficiency is a rare condition, in which plasma factor XI levels correlate poorly with the severity of haemorrhage. The condition is typically characterized by post-traumatic bleeding. The factor XI gene is located on chromosome 4 and contains 15 exons. More than 80 mutations have so far been described. We describe a novel mutation in the factor XI gene associated with mild factor XI deficiency. The patient, who is of Irish descent, has a history of post-traumatic bleeding and was found to have a borderline factor XI deficiency. DNA sequence analysis of the factor XI gene revealed a novel T to A mutation at nucleotide 168 resulting in the substitution of the cysteine residue at codon 38 with a stop codon (Cys38STOP). The mutation predicts the premature termination of translation of factor XI mRNA resulting in a truncated, and probably unstable, factor XI protein. The presence of the mutation is consistent with the patient's borderline factor XI deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905957     DOI: 10.1097/01.mbc.0000240926.80553.a7

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  1 in total

1.  Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.

Authors:  Zekai Avci; Baris Malbora; Mahmut Gokdemir; Suleyman Ozkan; Namik Ozbek
Journal:  Pediatr Cardiol       Date:  2007-09-20       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.